Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility

NCT04748796 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Septic Shock
Tachycardia
Mortality During Septic Shock
Beta-blocker

Interventions

OTHER: echocardiography
DRUG: Landiolol

Sponsor

Centre Hospitalier Universitaire, Amiens

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]